000 | 01926 a2200517 4500 | ||
---|---|---|---|
005 | 20250515040051.0 | ||
264 | 0 | _c20061130 | |
008 | 200611s 0 0 eng d | ||
022 | _a1570-1638 | ||
024 | 7 |
_a10.2174/157016306778108893 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRensen, Patrick C N | |
245 | 0 | 0 |
_aSelective targeting of liposomes to macrophages using a ligand with high affinity for the macrophage scavenger receptor class A. _h[electronic resource] |
260 |
_bCurrent drug discovery technologies _cJun 2006 |
||
300 |
_a135-44 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBinding, Competitive |
650 | 0 | 4 |
_aCD36 Antigens _xmetabolism |
650 | 0 | 4 |
_aCarbon Monoxide _xadministration & dosage |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aDexamethasone _xadministration & dosage |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
650 | 0 | 4 | _aLigands |
650 | 0 | 4 |
_aLiposomes _xadministration & dosage |
650 | 0 | 4 |
_aLithocholic Acid _xadministration & dosage |
650 | 0 | 4 |
_aLiver _xdrug effects |
650 | 0 | 4 |
_aMacrophages _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMolecular Structure |
650 | 0 | 4 |
_aOligodeoxyribonucleotides _xpharmacology |
650 | 0 | 4 |
_aScavenger Receptors, Class A _xmetabolism |
650 | 0 | 4 |
_aSpleen _xdrug effects |
650 | 0 | 4 |
_aSurface-Active Agents _xadministration & dosage |
700 | 1 | _aGras, J C Emile | |
700 | 1 | _aLindfors, Eva K | |
700 | 1 | _avan Dijk, Ko Willems | |
700 | 1 | _aJukema, J Wouter | |
700 | 1 | _avan Berkel, Theo J C | |
700 | 1 | _aBiessen, Erik A L | |
773 | 0 |
_tCurrent drug discovery technologies _gvol. 3 _gno. 2 _gp. 135-44 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2174/157016306778108893 _zAvailable from publisher's website |
999 |
_c16511757 _d16511757 |